Full Year 2024 Trading Update
FY24 revenues £177m, EBITDA £40.0-40.5m; Peters Surgical and Syntacoll acquisitions integrating well.
vs expectations: in line with consensus expectations
- Revenue £177m (prior £126.2m)
- EBITDA £40.0-40.5m (prior £29.7m)
- Adjusted Pre-tax profit £29.2-29.7m (prior £25.9m)
Select text to share a quote on X · sign in to keep highlights & notes in your AMS notes
Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), a world-leading specialist in tissue-healing technologies, today announces a trading update for the twelve months ended 31 December 2024. The Group expects to announce its Full Year results on 19 March 2025.
Following the acquisition of Syntacoll on 1 March 2024 and the transformative acquisition of Peters Surgical on 1 July 2024, excellent progress has been made on integrating both businesses, and the enlarged Group is performing well, with strong growth continuing across all surgical product categories. In response to changing market dynamics, planned strategic initiatives within the Woundcare business are also being successfully executed, which are expected to positively impact margins in 2025.
The Group expects to report Full Year 2024 revenues of approximately £177 million (2023: £126.2 million), EBITDA of £40.0 - £40.5 million (2023: £ 29.7 million) and adjusted Pre-tax profit of £29.2 - 29.7 million (2023: £25.9 million).
Chris Meredith, Chief Executive Officer of AMS, said: "The progress we made in the second half of 2024 has strengthened the confidence we have in the strategic rationale for the recent acquisitions of Peters Surgical and Syntacoll. The synergistic benefits they represent to AMS, in terms of products, expertise, geographic reach and scale, are clearer than ever. As we start the new year as an enlarged and more competitive Group, I remain confident and excited about the growth and opportunities that we expect in 2025 and beyond."
| ICR Healthcare | Tel: +44 (0) 20 3709 5700 |
| Mary-Jane Elliott / Lucy Featherstone | AMS@icrhealthcare.com |
| Investec Bank PLC (NOMAD & Broker) | Tel: +44 (0) 20 7597 5970 |
| Gary Clarence / David Anderson | |
| HSBC Bank plc (Broker) | Tel: 44 (0) 20 7991 8888 |
Joe Weaving / Stephanie Cornish
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.